Web of Science: 26 citations, Scopus: 27 citations, Google Scholar: citations,
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis
Cano-Jiménez, Esteban (Hospital Universitario Lucus Augusti (Lugo))
Vázquez Rodríguez, Tomás (Hospital Universitario Lucus Augusti (Lugo))
Martín-Robles, Irene (Hospital Universitario Lucus Augusti (Lugo))
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau)
Juan García, Javier (Complejo Asistencial Universitario de León)
Bollo de Miguel, Elena (Complejo Asistencial Universitario de León)
Robles-Pérez, Alejandro (Institut d'Investigació Biomèdica de Bellvitge)
Ferrer Galván, Marta (Hospital Universitario Virgen Macarena (Sevilla, Andalusia))
Mouronte Roibas, Cecilia (Complexo Hospitalario Universitario de Vigo)
Herrera Lara, Susana (Hospital Universitari Doctor Peset (València))
Bermudo, Guadalupe (Institut d'Investigació Biomèdica de Bellvitge)
García Moyano, Marta (Hospital Universitario de Cruces (Barakaldo, País Basc))
Rodríguez Portal, Jose Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia))
Sellarés Torres, Jacobo (Hospital Clínic i Provincial de Barcelona)
Narváez, Javier (Institut d'Investigació Biomèdica de Bellvitge)
Molina-Molina, María (Institut d'Investigació Biomèdica de Bellvitge)

Date: 2021
Abstract: Rheumatoid arthritis (RA) is a systemic autoimmune disease whose main extra-articular organ affected is the lung, sometimes in the form of diffuse interstitial lung disease (ILD) and conditions the prognosis. A multicenter, observational, descriptive and cross-sectional study of consecutive patients diagnosed with RA-ILD. Demographic, analytical, respiratory functional and evolution characteristics were analyzed to evaluate the predictors of progression and mortality. 106 patients were included. The multivariate analysis showed that the diagnostic delay was an independent predictor of mortality (HR 1. 11, CI 1. 01-1. 23, p = 0. 035). Also, age (HR 1. 33, 95% CI 1. 09-1. 62, p = 0. 0045), DLCO (%) (HR 0. 85, 95% CI 0. 73-0. 98, p = 0. 0246), and final SatO2 (%) in the 6MWT (HR 0. 62, 95% CI 0. 39-0. 99, p = 0. 0465) were independent predictor variables of mortality, as well as GAP index (HR 4. 65, 95% CI 1. 59-13. 54, p = 0. 0051) and CPI index (HR 1. 12, 95% CI 1. 03-1. 22, p = 0. 0092). The withdrawal of MTX or LFN after ILD diagnosis was associated with disease progression in the COX analysis (HR 2. 18, 95% CI 1. 14-4. 18, p = 0. 019). This is the first study that highlights the diagnostic delay in RA-ILD is associated with an increased mortality just like happens in IPF.
Rights: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Language: Anglès
Document: Article ; recerca ; Versió publicada
Subject: Adult ; Aged ; Aged, 80 and over ; Antirheumatic Agents ; Arthritis, Rheumatoid ; Cross-Sectional Studies ; Delayed Diagnosis ; Female ; Humans ; Leflunomide ; Lung Diseases, Interstitial ; Male ; Methotrexate ; Middle Aged ; Respiratory Tract Infections ; Spain
Published in: Scientific reports, Vol. 11 Núm. 1 (december 2021) , p. 9184, ISSN 2045-2322

DOI: 10.1038/s41598-021-88734-2
PMID: 33911185


11 p, 1.9 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles

 Record created 2023-02-16, last modified 2023-11-29



   Favorit i Compartir